Assessment of Pharmacokinetic Interaction Between Letermovir and Fluconazole in Healthy Participants
Author:
Affiliation:
1. Merck & Co., Inc. Kenilworth New Jersey USA
2. Celerion Tempe Arizona USA
Funder
Merck Sharp & Dohme Corp
Publisher
Wiley
Subject
Pharmacology (medical),Pharmaceutical Science
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.852
Reference19 articles.
1. Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review
Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review
2. The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase
3. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
4. Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects
5. Pharmacokinetic Drug‐Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Drug interactions of tacrolimus with letermovir and azole antifungals following hematopoietic stem cell transplantation: A retrospective observational analysis;Pharmacology Research & Perspectives;2023-08
2. Lactic acidosis after allogeneic haematopoietic stem cell transplantation potentially related to letermovir;British Journal of Clinical Pharmacology;2023-02-19
3. Evaluation of the inhibitory effects of itraconazole on letermovir;British Journal of Clinical Pharmacology;2023-02-12
4. Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients;Antimicrobial Agents and Chemotherapy;2022-08-16
5. Pharmacokinetics, Safety, and Tolerability of Letermovir Following Single‐ and Multiple‐Dose Administration in Healthy Japanese Subjects;Clinical Pharmacology in Drug Development;2022-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3